- Home
- BWLP vs ZLAB Comparison
BWLP vs ZLAB Comparison
Compare BWLP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- ZLAB
- Stock Information
- Founded
- BWLP 1935
- ZLAB 2013
- Country
- BWLP Singapore
- ZLAB China
- Employees
- BWLP N/A
- ZLAB N/A
- Industry
- BWLP Marine Transportation
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- ZLAB Health Care
- Exchange
- BWLP Nasdaq
- ZLAB Nasdaq
- Market Cap
- BWLP 1.9B
- ZLAB 1.8B
- IPO Year
- BWLP N/A
- ZLAB 2017
- Fundamental
- Price
- BWLP $12.76
- ZLAB $31.24
- Analyst Decision
- BWLP
- ZLAB Strong Buy
- Analyst Count
- BWLP 0
- ZLAB 4
- Target Price
- BWLP N/A
- ZLAB $52.50
- AVG Volume (30 Days)
- BWLP 255.5K
- ZLAB 976.3K
- Earning Date
- BWLP 01-01-0001
- ZLAB 11-12-2024
- Dividend Yield
- BWLP 24.68%
- ZLAB N/A
- EPS Growth
- BWLP 43.64
- ZLAB N/A
- EPS
- BWLP 3.64
- ZLAB N/A
- Revenue
- BWLP $3,510,244,000.00
- ZLAB $322,711,000.00
- Revenue This Year
- BWLP N/A
- ZLAB $48.34
- Revenue Next Year
- BWLP N/A
- ZLAB $47.12
- P/E Ratio
- BWLP $3.68
- ZLAB N/A
- Revenue Growth
- BWLP 57.96
- ZLAB 28.16
- 52 Week Low
- BWLP $10.32
- ZLAB $13.48
- 52 Week High
- BWLP $22.31
- ZLAB $36.60
- Technical
- Relative Strength Index (RSI)
- BWLP 33.59
- ZLAB 70.41
- Support Level
- BWLP $13.21
- ZLAB $31.52
- Resistance Level
- BWLP $13.58
- ZLAB $36.60
- Average True Range (ATR)
- BWLP 0.23
- ZLAB 1.36
- MACD
- BWLP -0.15
- ZLAB 0.34
- Stochastic Oscillator
- BWLP 2.94
- ZLAB 58.60
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.